Developing artificial intelligence-based precision therapeutics for patients with chronic inflammatory and autoimmune diseases
Torrance, California
Joined April 2020
- Tweets19
- Following20
- Followers74
- Likes26
We are thrilled to announce that Tony Zingale has been appointed as an Observer to our Board of Directors.
Cheers to dynamic teams!
#biotech #softwaredevelopment #precisionmedicine
athostx.com/news-posts/tony-…
Excited to be partnering with the Univ. of Ioannina! More collaboration = exciting research ahead
finance.yahoo.com/news/athos…
Athos Therapeutics Inc retweeted
🎉 Congratulations to @biocom #LA member company - @athostx for receiving regulatory approval to begin phase 1 of clinical trials! 🙌 We are excited to see what the future holds for Team Athos! #lifescience #LongLA
Incredible news to share this morning.
Athos Tx has received approval to commence Phase I clinical trail in Australia! Learn more about it in our official announcement.
prnewswire.com/news-releases…
Incredible news to share this morning.
Athos Tx has received approval to commence Phase I clinical trail in Australia! Learn more about it in our official announcement.
prnewswire.com/news-releases…
Excited to share a quick video summary of our company from our President & CEO!
#biotech #startup #autoimmunedisease
New collaboration underway! Check out our latest announcement with @CalTech prn.to/3KqXQFt
Athos Therapeutics Inc retweeted
new, expanded partnerships
@athostx enter #research collab for #PrecisionMedicine in #InflammatoryBowelDisease
@PharmaPointRx expands partnership with NC -based #medical-#surgical #Healthcare practice
@geekplusrobot, @SystemexAutomat join to explore mobile #robot deployment
ALT Image Source: https://www.telematicswire.net/geek-and-systemex-automation-sign-partnership-to-expand-autonomous-mobile-robot-deployments-in-north-america/
Here at Athos, we have exciting news to share.
Yiannis Monovoukas and Monte Stettin have been appointed as Advisors and Observers to the Board of Directors of Athos Therapeutics.
For more details, read our most recent press release!
#biotech
prnewswire.com/news-releases…
Abraham Verghese MD, Appointed to the Board of Directors of Athos Therapeutics prn.to/3llIg23
Athos Therapeutics completes an oversubscribed $15MM Series A financing prn.to/3DjzxFb
Athos Therapeutics Announces their Corporate Circle Membership to the Crohn's & Colitis Foundation prn.to/3mTYDDk
#athostx #crohnsdisease #ulcerativecolitis #biotech #systemsbiology #precisionmedicine #drugdevelopment
Athos to perform a molecular analysis of patient samples from the Cleveland Clinic #IBD #athostx #biotech #drugdiscovery #precisionmedicine #systemsbiology prn.to/2UHuNbe
Our SAB Chair Dr. Claudio Fiocchi and CEO Dr. Dimitrios Iliopoulos have published an intriguing and informative article regarding the power of systems biology and how it relates to the treatment of IBD pubmed.ncbi.nlm.nih.gov/3343… #systemsbiology #IBD #athostx #biotech
We are participating in both the Biotech Showcase and BIO @ JPM virtual partnering conferences! #JPM2021 #biotech #athostx #drugdiscovery #precisionmedicine #systemsbiology prn.to/2Le0gNB
Athos Therapeutics Announces Appointment of Chief Business Officer #biotech #drugdiscovery #precisionmedicine prn.to/3jUi5fQ